Identification of ligand binding site on RXRγ using molecular docking and dynamics methods

Area of Science:

• Biochemistry and Molecular Biology
• Structural Biology
• Cancer Research

Background:

• Retinoid X receptors (RXRs) are crucial targets for cancer chemotherapy.
• Understanding RXR subtypes, particularly RXRγ, is vital for developing novel cancer therapeutics.
• Limited structural information exists for the RXRγ ligand binding site.

Purpose of the Study:

• To elucidate the ligand binding site of RXRγ.
• To characterize the RXRγ ligand binding mode.
• To compare the structural differences and binding modes among RXRα, RXRβ, and RXRγ.

Main Methods:

• Sequence alignment and molecular dynamics simulations were employed.
• Identification and characterization of the RXRγ ligand binding pocket.
• Comparative analysis of RXR subtype binding sites and ligand interactions.

Main Results:

• The RXRγ ligand binding site comprises helices H5, H10, β-sheet s1, and an end loop.
• 9-cis retinoic acid forms hydrogen bonds with Ala106, a salt bridge with Arg95, and π-π interactions with Phe217/Phe218.
• RXRγ possesses a larger, distinct binding pocket compared to RXRα and RXRβ, leading to a unique ligand 'standing' pose.

Conclusions:

• The structural and binding differences of RXRγ offer new insights for targeted cancer drug design.
• Targeting RXRγ's unique binding pocket may lead to more selective and effective cancer chemotherapies.
• Further structural studies of RXRγ are warranted to fully exploit its therapeutic potential.